Kiniksa Pharmaceuticals International, plc (KNSA) › Total LiabilitiesKiniksa Pharmaceuticals International, plc (KNSA) — Total LiabilitiesAnnual figures by period end, from SEC filings.2017-12-31: $17.43M2018-12-31: $42.70M2019-12-31: $29.11M2020-12-31: $37.53M2021-12-31: $47.76M2022-12-31: $63.52M2023-12-31: $87.48M2024-12-31: $142.12M2025-12-31: $196.03M$196.03M2017-12-31Total Liabilities (USD)2025-12-31Period endedTotal LiabilitiesChange YoYSource filing2025-12-31$196.03M+37.9%2026-02-24Balance as of period end2024-12-31$142.12M+62.5%2026-02-24Balance as of period end2023-12-31$87.48M+37.7%2025-02-25Balance as of period end2022-12-31$63.52M+33.0%2024-02-28Balance as of period end2021-12-31$47.76M+27.3%2023-03-02Balance as of period end2020-12-31$37.53M+28.9%2022-02-24Balance as of period end2019-12-31$29.11M-31.8%2021-02-25Balance as of period end2018-12-31$42.70M+145.0%2020-03-05Balance as of period end2017-12-31$17.43M—2019-03-12Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)